Ramipril reduces incidence and prolongates latency time of radiation-induced rat myelopathy after photon and carbon ion irradiation

To test the hypothesis that the use of an angiotensin-converting enzyme inhibitor (ACEi) during radiotherapy may be ameliorative for treatment-related normal tissue damage, a pilot study was conducted with the clinically approved (ACE) inhibitor ramipril on the outcome of radiation-induced myelopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Saager, Maria, Hahn, Eric W, Peschke, Peter, Brons, Stephan, Huber, Peter E, Debus, Jürgen, Karger, Christian P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Regular Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482157/
https://www.ncbi.nlm.nih.gov/pubmed/32657322
http://dx.doi.org/10.1093/jrr/rraa042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482157/
https://www.ncbi.nlm.nih.gov/pubmed/32657322
http://dx.doi.org/10.1093/jrr/rraa042

Ejemplares similares